BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, Liu Q, George DL, Ahima RS, Murphy ME. The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Rep 2016;14:2413-25. [PMID: 26947067 DOI: 10.1016/j.celrep.2016.02.037] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Stempkowska A, Walicka M, Franek E, Naruszewicz M, Panczyk M, Sanchak Y, Filipek A. Hp1-1 as a Genetic Marker Regulating Inflammation and the Possibility of Developing Diabetic Complications in Patients with Type 2 Diabetes-Cohort Studies. Genes (Basel) 2020;11:E1253. [PMID: 33114431 DOI: 10.3390/genes11111253] [Reference Citation Analysis]
2 Barnoud T, Parris JLD, Murphy ME. Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism. Oncotarget 2019;10:1217-23. [PMID: 30838093 DOI: 10.18632/oncotarget.26660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zwezdaryk K, Sullivan D, Saifudeen Z. The p53/Adipose-Tissue/Cancer Nexus. Front Endocrinol (Lausanne) 2018;9:457. [PMID: 30158901 DOI: 10.3389/fendo.2018.00457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Diakite B, Kassogue Y, Dolo G, Wang J, Neuschler E, Kassogue O, Keita ML, Traore CB, Kamate B, Dembele E, Nadifi S, Murphy RL, Doumbia S, Hou L, Maiga M. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies. BMC Med Genet 2020;21:206. [PMID: 33076844 DOI: 10.1186/s12881-020-01133-8] [Reference Citation Analysis]
5 Kung CP, Basu S, Murphy ME. A link between TP53 polymorphisms and metabolism. Mol Cell Oncol 2016;3:e1173769. [PMID: 27652322 DOI: 10.1080/23723556.2016.1173769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Montazeri-Najababady N, Dabbaghmanesh MH, Nasimi N, Sohrabi Z, Chatrabnous N. The association between TP53 rs1625895 polymorphism and the risk of sarcopenic obesity in Iranian older adults: a case-control study. BMC Musculoskelet Disord 2021;22:438. [PMID: 33985476 DOI: 10.1186/s12891-021-04314-5] [Reference Citation Analysis]
7 Hallenborg P, Jensen BAH, Fjære E, Petersen RK, Belmaâti MS, Rasmussen SS, Gunnarsson JP, Lauritzen P, Cheng KKY, Hermansson M, Sonne SB, Ejsing CS, Xu A, Kratchmarova I, Krüger M, Madsen L, Kristiansen K, Blagoev B. Adipose MDM2 regulates systemic insulin sensitivity. Sci Rep 2021;11:21839. [PMID: 34750429 DOI: 10.1038/s41598-021-01240-3] [Reference Citation Analysis]
8 Barnoud T, Parris JLD, Murphy ME. Common genetic variants in the TP53 pathway and their impact on cancer. J Mol Cell Biol 2019;11:578-85. [PMID: 31152665 DOI: 10.1093/jmcb/mjz052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
9 Cho JH, Patel B, Bonala S, Mansouri H, Manne S, Vadrevu SK, Ghouse S, Kung CP, Murphy ME, Astrinidis A, Henske EP, Kwiatkowski DJ, Markiewski MM, Karbowniczek M. The Codon 72 TP53 Polymorphism Contributes to TSC Tumorigenesis through the Notch-Nodal Axis. Mol Cancer Res 2019;17:1639-51. [PMID: 31088907 DOI: 10.1158/1541-7786.MCR-18-1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Cao H, Chen X, Wang Z, Wang L, Xia Q, Zhang W. The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation. Cell Death Discov 2020;6:53. [PMID: 32595984 DOI: 10.1038/s41420-020-0287-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
11 Chen LL, Wang WJ. p53 regulates lipid metabolism in cancer. Int J Biol Macromol 2021;192:45-54. [PMID: 34619274 DOI: 10.1016/j.ijbiomac.2021.09.188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Pedroza-diaz J, Arroyave-ospina JC, Serna Salas S, Moshage H. Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease. Antioxidants 2022;11:975. [DOI: 10.3390/antiox11050975] [Reference Citation Analysis]
13 Budina-Kolomets A, Barnoud T, Murphy ME. The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53. Cancer Biol Ther 2018;19:1033-8. [PMID: 30010463 DOI: 10.1080/15384047.2018.1472194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Nam HJ, Kim YE, Moon BS, Kim HY, Jung D, Choi S, Jang JW, Nam DH, Cho H. Azathioprine antagonizes aberrantly elevated lipid metabolism and induces apoptosis in glioblastoma. iScience 2021;24:102238. [PMID: 33748720 DOI: 10.1016/j.isci.2021.102238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Caldez MJ, Bjorklund M, Kaldis P. Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division. Hepatol Int 2020;14:463-74. [PMID: 32578019 DOI: 10.1007/s12072-020-10066-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
16 Okamoto K, Koda M, Okamoto T, Onoyama T, Miyoshi K, Kishina M, Matono T, Kato J, Tokunaga S, Sugihara T, Hiramatsu A, Hyogo H, Tobita H, Sato S, Kawanaka M, Hara Y, Hino K, Chayama K, Murawaki Y, Isomoto H. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLoS One 2020;15:e0219412. [PMID: 32106257 DOI: 10.1371/journal.pone.0219412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Gnanapradeepan K, Leu JI, Basu S, Barnoud T, Good M, Lee JV, Quinn WJ, Kung CP, Ahima R, Baur JA, Wellen KE, Liu Q, Schug ZT, George DL, Murphy ME. Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser. Elife 2020;9:e55994. [PMID: 33170774 DOI: 10.7554/eLife.55994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Chen T, Wu H, Chen X, Xie R, Wang F, Sun H, Chen L. p53 Mediates GnRH Secretion via Lin28/let-7 System in GT1-7 Cells. Diabetes Metab Syndr Obes 2020;13:4681-8. [PMID: 33299335 DOI: 10.2147/DMSO.S279901] [Reference Citation Analysis]
19 Du J, Shen L, Tan Z, Zhang P, Zhao X, Xu Y, Gan M, Yang Q, Ma J, Jiang A, Tang G, Jiang Y, Jin L, Li M, Bai L, Li X, Wang J, Zhang S, Zhu L. Betaine Supplementation Enhances Lipid Metabolism and Improves Insulin Resistance in Mice Fed a High-Fat Diet. Nutrients 2018;10:E131. [PMID: 29373534 DOI: 10.3390/nu10020131] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
20 Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME. The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. Front Endocrinol (Lausanne) 2018;9:124. [PMID: 29695998 DOI: 10.3389/fendo.2018.00124] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 15.0] [Reference Citation Analysis]
21 Eyres M, Lanfredini S, Xu H, Burns A, Blake A, Willenbrock F, Goldin R, Hughes D, Hughes S, Thapa A, Vavoulis D, Hubert A, D'Costa Z, Sabbagh A, Abraham AG, Blancher C, Jones S, Verrill C, Silva M, Soonawalla Z, Maughan T, Schuh A, Mukherjee S, O'Neill E. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes. Gastroenterology 2021;161:653-668.e16. [PMID: 33915173 DOI: 10.1053/j.gastro.2021.04.044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Lodhi N, Singh R, Rajput SP, Saquib Q. SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection. Int J Mol Sci 2021;22:8660. [PMID: 34445373 DOI: 10.3390/ijms22168660] [Reference Citation Analysis]
23 Lacroix M, Riscal R, Arena G, Linares LK, Le Cam L. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Mol Metab 2020;33:2-22. [PMID: 31685430 DOI: 10.1016/j.molmet.2019.10.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
24 Prokesch A, Graef FA, Madl T, Kahlhofer J, Heidenreich S, Schumann A, Moyschewitz E, Pristoynik P, Blaschitz A, Knauer M, Muenzner M, Bogner-Strauss JG, Dohr G, Schulz TJ, Schupp M. Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis. FASEB J 2017;31:732-42. [PMID: 27811061 DOI: 10.1096/fj.201600845R] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
25 Słomiński B, Skrzypkowska M, Ryba-Stanisławowska M, Myśliwiec M, Trzonkowski P. Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes. J Mol Med (Berl) 2021;99:675-83. [PMID: 33495869 DOI: 10.1007/s00109-020-02035-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Ma S, Luo Z, Zhou X, Zhou H, Chen L, Zhang W. Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery. Clin Exp Pharmacol Physiol 2021. [PMID: 34606635 DOI: 10.1111/1440-1681.13599] [Reference Citation Analysis]
27 Yan Z, Miao X, Zhang B, Xie J. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. Life Sciences 2018;215:64-72. [DOI: 10.1016/j.lfs.2018.10.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
28 Jung IR, Anokye-Danso F, Jin S, Ahima RS, Kim SF. IPMK modulates hepatic glucose production and insulin signaling. J Cell Physiol 2022. [PMID: 35822903 DOI: 10.1002/jcp.30827] [Reference Citation Analysis]
29 Chen T, Chen C, Wu H, Chen X, Xie R, Wang F, Sun H, Chen L. Overexpression of p53 accelerates puberty in high-fat diet-fed mice through Lin28/let-7 system. Exp Biol Med (Maywood) 2021;246:66-71. [PMID: 32996351 DOI: 10.1177/1535370220961320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Duffy DL, McDonald SP, Hayhurst B, Panagiotopoulos S, Smith TJ, Wang XL, Wilcken DE, Duarte NL, Mathews J, Hoy WE. Familial aggregation of albuminuria and arterial hypertension in an Aboriginal Australian community and the contribution of variants in ACE and TP53. BMC Nephrol 2016;17:183. [PMID: 27871254 DOI: 10.1186/s12882-016-0396-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
31 Contreras EG, Sierralta J, Glavic A. p53 is required for brain growth but is dispensable for resistance to nutrient restriction during Drosophila larval development. PLoS One 2018;13:e0194344. [PMID: 29621246 DOI: 10.1371/journal.pone.0194344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lahalle A, Lacroix M, De Blasio C, Cissé MY, Linares LK, Le Cam L. The p53 Pathway and Metabolism: The Tree That Hides the Forest. Cancers (Basel) 2021;13:E133. [PMID: 33406607 DOI: 10.3390/cancers13010133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Labuschagne CF, Zani F, Vousden KH. Control of metabolism by p53 - Cancer and beyond. Biochim Biophys Acta Rev Cancer 2018;1870:32-42. [PMID: 29883595 DOI: 10.1016/j.bbcan.2018.06.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 16.8] [Reference Citation Analysis]
34 Di Giovannantonio M, Harris BH, Zhang P, Kitchen-Smith I, Xiong L, Sahgal N, Stracquadanio G, Wallace M, Blagden S, Lord S, Harris D, Harris AHL, Buffa FM, Bond GL. Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits. J Med Genet 2021;58:392-9. [PMID: 32591342 DOI: 10.1136/jmedgenet-2019-106799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kung C, Weber JD. It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy. Front Cell Dev Biol 2022;10:818744. [DOI: 10.3389/fcell.2022.818744] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Krstic J, Reinisch I, Schupp M, Schulz TJ, Prokesch A. p53 Functions in Adipose Tissue Metabolism and Homeostasis. Int J Mol Sci 2018;19:E2622. [PMID: 30181511 DOI: 10.3390/ijms19092622] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
37 Chen L, Wang W. p53 regulates lipid metabolism in cancer. International Journal of Biological Macromolecules 2021;192:45-54. [DOI: 10.1016/j.ijbiomac.2021.09.188] [Reference Citation Analysis]
38 Kung CP, Maggi LB Jr, Weber JD. The Role of RNA Editing in Cancer Development and Metabolic Disorders. Front Endocrinol (Lausanne) 2018;9:762. [PMID: 30619092 DOI: 10.3389/fendo.2018.00762] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 8.8] [Reference Citation Analysis]
39 Sabir JSM, El Omri A, Shaik NA, Banaganapalli B, Hajrah NH, Zrelli H, Arfaoui L, Awan ZA, Shaikh Omar AM, Mohammed A, Alharbi MG, Alhebshi AM, Jansen RK, Khan M. The genetic association study of TP53 polymorphisms in Saudi obese patients. Saudi J Biol Sci 2019;26:1338-43. [PMID: 31762593 DOI: 10.1016/j.sjbs.2019.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Basu S, Barnoud T, Kung CP, Reiss M, Murphy ME. The African-specific S47 polymorphism of p53 alters chemosensitivity. Cell Cycle 2016;15:2557-60. [PMID: 27484708 DOI: 10.1080/15384101.2016.1215390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
41 Chu DT, Tao Y. Molecular connections of obesity and aging: a focus on adipose protein 53 and retinoblastoma protein. Biogerontology 2017;18:321-32. [PMID: 28357524 DOI: 10.1007/s10522-017-9698-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
42 Strycharz J, Drzewoski J, Szemraj J, Sliwinska A. Is p53 Involved in Tissue-Specific Insulin Resistance Formation? Oxid Med Cell Longev 2017;2017:9270549. [PMID: 28194257 DOI: 10.1155/2017/9270549] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
43 Guo D, Fang L, Yu X, Wang C, Wang Y, Guo W. Different Roles of TP53 Codon 72 Polymorphism in Type 2 Diabetes and Its Complications: Evidence from a Case-Control Study on a Chinese Han Population. Int J Gen Med 2021;14:4259-68. [PMID: 34393505 DOI: 10.2147/IJGM.S322840] [Reference Citation Analysis]
44 Orr BA, Clay MR, Pinto EM, Kesserwan C. An update on the central nervous system manifestations of Li-Fraumeni syndrome. Acta Neuropathol 2020;139:669-87. [PMID: 31468188 DOI: 10.1007/s00401-019-02055-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
45 Haghnazari L, Sabzi R. Relationship between TP53 and interleukin-6 gene variants and the risk of types 1 and 2 diabetes mellitus development in the Kermanshah province. J Med Life 2021;14:37-44. [PMID: 33767783 DOI: 10.25122/jml-2019-0150] [Reference Citation Analysis]
46 Araujo N, Sledziona J, Noothi SK, Burikhanov R, Hebbar N, Ganguly S, Shrestha-Bhattarai T, Zhu B, Katz WS, Zhang Y, Taylor BS, Liu J, Chen L, Weiss HL, He D, Wang C, Morris AJ, Cassis LA, Nikolova-Karakashian M, Nagareddy PR, Melander O, Evers BM, Kern PA, Rangnekar VM. Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity. Front Oncol 2022;12:860446. [PMID: 35425699 DOI: 10.3389/fonc.2022.860446] [Reference Citation Analysis]
47 Krstic J, Galhuber M, Schulz TJ, Schupp M, Prokesch A. p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. Int J Mol Sci 2018;19:E921. [PMID: 29558460 DOI: 10.3390/ijms19030921] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
48 Montazeri-najafabady N, Dabbaghmanesh MH, Nasimi N, Sohrabi Z, Estedlal A, Asmarian N. Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms and their haplotypes in susceptibility to sarcopenia in Iranian older adults. BMC Geriatr 2022;22. [DOI: 10.1186/s12877-022-02765-6] [Reference Citation Analysis]
49 Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol 2021:S1044-579X(21)00060-2. [PMID: 33785447 DOI: 10.1016/j.semcancer.2021.03.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 20.0] [Reference Citation Analysis]
50 Broggi G, Tirrò E, Alzoubi H, Arcella A, Gianno F, Antonelli M, Minasi S, Vigneri P, Certo F, Altieri R, Barbagallo GMV, Miele E, Caltabiano R, Giangaspero F. Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor. Neuropathology 2022. [PMID: 35042275 DOI: 10.1111/neup.12799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Kung CP, Murphy ME. The role of the p53 tumor suppressor in metabolism and diabetes. J Endocrinol 2016;231:R61-75. [PMID: 27613337 DOI: 10.1530/JOE-16-0324] [Cited by in Crossref: 77] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
52 Viñals-Labañino CP, Velazquez-Bustamante AE, Vargas-Santiago SI, Arenas-Sordo ML. Usefulness of Cerebral Palsy Curves in Mexican Patients: A Cross-Sectional Study. J Child Neurol 2019;34:332-8. [PMID: 30854918 DOI: 10.1177/0883073819830560] [Reference Citation Analysis]
53 Omrani-Nava V, Hedayatizadeh-Omran A, Alizadeh-Navaei R, Mokhberi V, Jalalian R, Janbabaei G, Amjadi O, Rahmatpour G, Mozaffari A. TP53 single nucleotide polymorphism (rs1042522) in Iranian patients with coronary artery disease. Biomed Rep 2018;9:259-65. [PMID: 30271603 DOI: 10.3892/br.2018.1121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Itahana Y, Itahana K. Emerging Roles of p53 Family Members in Glucose Metabolism. Int J Mol Sci 2018;19:E776. [PMID: 29518025 DOI: 10.3390/ijms19030776] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
55 Feroz W, Sheikh AMA. Exploring the multiple roles of guardian of the genome: P53. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00089-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Naidoo P, Naidoo RN, Ramkaran P, Chuturgoon AA. Effect of maternal HIV infection, BMI and NOx air pollution exposure on birth outcomes in South African pregnant women genotyped for the p53 Pro72Arg (rs1042522). Int J Immunogenet 2020;47:414-29. [PMID: 32080966 DOI: 10.1111/iji.12481] [Reference Citation Analysis]
57 Lee YK, Chung Y, Lee JH, Chun JM, Park JH. The Intricate Role of p53 in Adipocyte Differentiation and Function. Cells 2020;9:E2621. [PMID: 33297294 DOI: 10.3390/cells9122621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Jackson RA, Nguyen ML, Barrett AN, Tan YY, Choolani MA, Chen ES. Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility. Cell Mol Life Sci 2016;73:4001-17. [PMID: 27245382 DOI: 10.1007/s00018-016-2276-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Rosen ED. Epigenomic and transcriptional control of insulin resistance. J Intern Med 2016;280:443-56. [PMID: 27739225 DOI: 10.1111/joim.12547] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lacroix M, Linares LK, Rueda-Rincon N, Bloch K, Di Michele M, De Blasio C, Fau C, Gayte L, Blanchet E, Mairal A, Derua R, Cardona F, Beuzelin D, Annicotte JS, Pirot N, Torro A, Tinahones FJ, Bernex F, Bertrand-Michel J, Langin D, Fajas L, Swinnen JV, Le Cam L. The multifunctional protein E4F1 links P53 to lipid metabolism in adipocytes. Nat Commun 2021;12:7037. [PMID: 34857760 DOI: 10.1038/s41467-021-27307-3] [Reference Citation Analysis]
61 Kumar D, Pandya SK, Varshney S, Shankar K, Rajan S, Srivastava A, Gupta A, Gupta S, Vishwakarma AL, Misra A, Gaikwad AN. Temporal immmunometabolic profiling of adipose tissue in HFD-induced obesity: manifestations of mast cells in fibrosis and senescence. Int J Obes 2019;43:1281-94. [DOI: 10.1038/s41366-018-0228-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
62 Antoun S, Atallah D, Tahtouh R, Alaaeddine N, Moubarak M, Khaddage A, Ayoub EN, Chahine G, Hilal G. Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles. Cancer Cell Int 2018;18:14. [PMID: 29422776 DOI: 10.1186/s12935-018-0514-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
63 Humpton T, Vousden KH. Taking up the reins of power: metabolic functions of p53. J Mol Cell Biol 2019;11:610-4. [PMID: 31282931 DOI: 10.1093/jmcb/mjz065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
64 Dong K, Zhao Q, Xue Y, Wei Y, Zhang Y, Yang Y. TCTP participates in hepatic metabolism by regulating gene expression involved in insulin resistance. Gene 2021;768:145263. [PMID: 33122078 DOI: 10.1016/j.gene.2020.145263] [Reference Citation Analysis]
65 Lane D. p53: out of Africa. Genes Dev 2016;30:876-7. [PMID: 27083994 DOI: 10.1101/gad.281733.116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
66 Zhao Y, Wu L, Yue X, Zhang C, Wang J, Li J, Sun X, Zhu Y, Feng Z, Hu W. A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models. Elife 2018;7:e34701. [PMID: 29557783 DOI: 10.7554/eLife.34701] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
67 Kung CP, Liu Q, Murphy ME. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation. Cancer Biol Ther 2017;18:484-91. [PMID: 28475405 DOI: 10.1080/15384047.2017.1323595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
68 Kim BY, Lee SY, Chung SK. Differential Transcriptional Regulation of Polymorphic p53 Codon 72 in Metabolic Pathways. Int J Mol Sci 2021;22:10793. [PMID: 34639134 DOI: 10.3390/ijms221910793] [Reference Citation Analysis]
69 Du J, Zhang P, Gan M, Zhao X, Xu Y, Li Q, Jiang Y, Tang G, Li M, Wang J, Li X, Zhang S, Zhu L. MicroRNA-204-5p regulates 3T3-L1 preadipocyte proliferation, apoptosis and differentiation. Gene 2018;668:1-7. [DOI: 10.1016/j.gene.2018.05.036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
70 Altinkaya SO, Avcioglu SN, Sezer SD, Ceylaner S. Analysis of TP53 gene in uterine myomas: No mutations but P72R polymorphism is associated with myoma development. J Obstet Gynaecol Res 2019;45:2088-94. [PMID: 31357239 DOI: 10.1111/jog.14071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Zhang Y, Zeng SX, Hao Q, Lu H. Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner. Dev Biol 2017;423:34-45. [PMID: 28118981 DOI: 10.1016/j.ydbio.2017.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
72 Gunaratna RT, Santos A, Luo L, Nagi C, Lambertz I, Spier M, Conti CJ, Fuchs-Young RS. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model. Oncogene 2019;38:3535-50. [PMID: 30651598 DOI: 10.1038/s41388-018-0630-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
73 Basu S, Gnanapradeepan K, Barnoud T, Kung CP, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV, Murphy ME. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. Genes Dev 2018;32:230-43. [PMID: 29463573 DOI: 10.1101/gad.309062.117] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
74 Holter MM, Garibay D, Lee SA, Saikia M, McGavigan AK, Ngyuen L, Moore ES, Daugherity E, Cohen P, Kelly K, Weiss RS, Cummings BP. Hepatocyte p53 ablation induces metabolic dysregulation that is corrected by food restriction and vertical sleeve gastrectomy in mice. FASEB J 2020;34:1846-58. [PMID: 31914635 DOI: 10.1096/fj.201902214R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
75 De Souza C, Madden JA, Minn D, Kumar VE, Montoya DJ, Nambiar R, Zhu Z, Xiao WW, Tahmassebi N, Kathi H, Nelson N, Karnezis AN, Chien J. The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression. Int J Mol Sci 2020;21:E8025. [PMID: 33126568 DOI: 10.3390/ijms21218025] [Reference Citation Analysis]